Article: How Cell and Gene Therapy Manufacturing Will Evolve in 2024
Summary: In this BioSpace article from January’s Advanced Therapies Week in Miami, Catalent’s cell therapy expertise is highlighted. Reporter Charlotte LoBuono interviewed Catalent expert Rupa Pike, Ph.D., Global Head of Strategic Alliances for Cell Therapy, to discuss the manufacturing requirements for a specific cell therapy gaining popularity: CAR T cell therapies.
KEY LEARNINGS:
- BioSpace article from January’s Advanced Therapies Week in Miami, Catalent’s cell therapy expertise is highlighted
- Reporter Charlotte LoBuono interviewed Catalent expert Rupa Pike to discuss the manufacturing requirements for a specific cell therapy gaining popularity: CAR T cell therapies.